ABOUT INDEXING BOARD ARCHIVES AUTHOR GUIDELINES SUBMIT PAPER AUTHOR'S PAGE NEWS, EVENTS CONTACT
REVISTA DE CHIMIE
Cite as: Rev. Chim.
https://doi.org/10.37358/Rev.Chim.1949

OSIM Nr. R102355
ISSN Online 2668-8212
ISSN Print: 1582-9049
ISSN-L: 1582-9049

REVISTA DE CHIMIE Latest Issue

LATEST ISSUE >>>

   Volume 76, 2025
   Volume 75, 2024
   Volume 74, 2023
   Volume 73, 2022
   Volume 72, 2021
   Volume 71, 2020
   Volume 70, 2019
   Volume 69, 2018
   Volume 68, 2017
   Volume 67, 2016
   Volume 66, 2015
   Volume 65, 2014
   Volume 64, 2013
   Volume 63, 2012
   Volume 62, 2011
   Volume 61, 2010
   Volume 60, 2009
   Volume 59, 2008
   Volume 58, 2007
 
<<<< back

Revista de Chimie (Rev. Chim.), Year 2018, Volume 69, Issue 12, 3644-3647

https://doi.org/10.37358/RC.18.12.6810

Laura Mazilu, Dana Lucia Stanculeanu, Andreea Daniela Gheorghe, Adrian Paul Suceveanu, Razvan Hainarosie, Irinel Raluca Parepa, Ovidiu Bratu, Camelia Cristina Diaconu, Daniela Manuc, Anca Pantea Stoian, Andra Iulia Suceveanu

Specific Adverse Effects of Bevacizumab in the Treatment of Non-Squamous Non-Small Cell Lung Cancer (NSCLC) in Clinical Practice

Abstract:

Lung cancer is the most common cause of cancer-related mortality, and non-small cell lung cancer (NSCLC) represents about 85% of all lung cancers. In the last years, novel targeted therapies have been developed and approved in the treatment of NSCLC. Angiogenesis is a very complex process, and cancer angiogenesis is the most important event concerning cancer growth, invasion and metastasis. VEGF signalling pathway plays a significant role in cancer angiogenesis, and it is demonstrated that VEGF levels are correlated with increased angiogenesis and with poor prognosis and metastasis in NSCLC patients. Bevacizumab is a recombinant humanised monoclonal IgG1 antibody, it is one of the first agent used for anti-angiogenic treatment, and it was approved for the treatment of non-squamous NSCLC in combination with chemotherapy.
Keywords:
lung cancer; bevacizumab; chemotherapy

Issue: 2018, Volume 69, Issue 12
Pages: 3644-3647
Publication date: 2019/1/15
https://doi.org/10.37358/RC.18.12.6810
download pdf   Download Pdf Article
Creative Commons License
This article is published under the Creative Commons Attribution 4.0 International License
Citation Styles
Cite this article as:
MAZILU, L., STANCULEANU, D.L., GHEORGHE, A.D., SUCEVEANU, A.P., HAINAROSIE, R., PAREPA, I.R., BRATU, O., DIACONU, C.C., MANUC, D., STOIAN, A.P., SUCEVEANU, A.I., Specific Adverse Effects of Bevacizumab in the Treatment of Non-Squamous Non-Small Cell Lung Cancer (NSCLC) in Clinical Practice, Rev. Chim., 69(12), 2018, 3644-3647.

Vancouver
Mazilu L, Stanculeanu DL, Gheorghe AD, Suceveanu AP, Hainarosie R, Parepa IR, Bratu O, Diaconu CC, Manuc D, Stoian AP, Suceveanu AI. Specific Adverse Effects of Bevacizumab in the Treatment of Non-Squamous Non-Small Cell Lung Cancer (NSCLC) in Clinical Practice. Rev. Chim.[internet]. 2018 Dec;69(12):3644-3647. Available from: https://doi.org/10.37358/RC.18.12.6810


APA 6th edition
Mazilu, L., Stanculeanu, D.L., Gheorghe, A.D., Suceveanu, A.P., Hainarosie, R., Parepa, I.R.,... Suceveanu, A.I. (2018). Specific Adverse Effects of Bevacizumab in the Treatment of Non-Squamous Non-Small Cell Lung Cancer (NSCLC) in Clinical Practice. Revista de Chimie, 69(12), 3644-3647. https://doi.org/10.37358/RC.18.12.6810


Harvard
Mazilu, L., Stanculeanu, D.L., Gheorghe, A.D., Suceveanu, A.P., Hainarosie, R., Parepa, I.R., Bratu, O., Diaconu, C.C., Manuc, D., Stoian, A.P., Suceveanu, A.I. (2018). 'Specific Adverse Effects of Bevacizumab in the Treatment of Non-Squamous Non-Small Cell Lung Cancer (NSCLC) in Clinical Practice', Revista de Chimie, 69(12), pp. 3644-3647. https://doi.org/10.37358/RC.18.12.6810


IEEE
L. Mazilu, D.L. Stanculeanu, A.D. Gheorghe, A.P. Suceveanu, R. Hainarosie, I.R. Parepa, O. Bratu, C.C. Diaconu, D. Manuc, A.P. Stoian, A.I. Suceveanu, "Specific Adverse Effects of Bevacizumab in the Treatment of Non-Squamous Non-Small Cell Lung Cancer (NSCLC) in Clinical Practice". Revista de Chimie, vol. 69, no. 12, pp. 3644-3647, 2018. [online]. https://doi.org/10.37358/RC.18.12.6810


Text
Laura Mazilu, Dana Lucia Stanculeanu, Andreea Daniela Gheorghe, Adrian Paul Suceveanu, Razvan Hainarosie, Irinel Raluca Parepa, Ovidiu Bratu, Camelia Cristina Diaconu, Daniela Manuc, Anca Pantea Stoian, Andra Iulia Suceveanu,
Specific Adverse Effects of Bevacizumab in the Treatment of Non-Squamous Non-Small Cell Lung Cancer (NSCLC) in Clinical Practice,
Revista de Chimie,
Volume 69, Issue 12,
2018,
Pages 3644-3647,
ISSN 2668-8212,
https://doi.org/10.37358/RC.18.12.6810.
(https://revistadechimie.ro/Articles.asp?ID=6810)
Keywords: lung cancer; bevacizumab; chemotherapy


RIS
TY - JOUR
T1 - Specific Adverse Effects of Bevacizumab in the Treatment of Non-Squamous Non-Small Cell Lung Cancer (NSCLC) in Clinical Practice
A1 - Mazilu, Laura
A2 - Stanculeanu, Dana Lucia
A3 - Gheorghe, Andreea Daniela
A4 - Suceveanu, Adrian Paul
A5 - Hainarosie, Razvan
A6 - Parepa, Irinel Raluca
A7 - Bratu, Ovidiu
A8 - Diaconu, Camelia Cristina
A9 - Manuc, Daniela
A10 - Stoian, Anca Pantea
A11 - Suceveanu, Andra Iulia
JF - Revista de Chimie
JO - Rev. Chim.
PB - Revista de Chimie SRL
SN - 2668-8212
Y1 - 2018
VL - 69
IS - 12
SP - 3644
EP - 3647
UR - https://doi.org/10.37358/RC.18.12.6810
KW - lung cancer
KW - bevacizumab
KW - chemotherapy
ER -


BibTex
@article{RevCh2018P3644,
author = {Mazilu Laura and Stanculeanu Dana Lucia and Gheorghe Andreea Daniela and Suceveanu Adrian Paul and Hainarosie Razvan and Parepa Irinel Raluca and Bratu Ovidiu and Diaconu Camelia Cristina and Manuc Daniela and Stoian Anca Pantea and Suceveanu Andra Iulia},
title = {Specific Adverse Effects of Bevacizumab in the Treatment of Non-Squamous Non-Small Cell Lung Cancer (NSCLC) in Clinical Practice},
journal = {Revista de Chimie},
volume = {69},
number = {12},
pages = {3644-3647},
year = {2018},
issn = {2668-8212},
doi = {https://doi.org/10.37358/RC.18.12.6810},
url = {https://revistadechimie.ro/Articles.asp?ID=6810}
}
 
<<<< back
 
PUBLISHING SECTION
Author Guidelines
 * Paper Drafting
 * Paper Template
 * Ethical Statement
 * Paper Submission
Ghidul Autorului (ro)
Submit Paper
Author's Page
Publishing Ethics
Peer Review Process
Open Access & Archiving Policy
 Search Authors
 LATEST NEWS
REvista de Chimie NUMAR OMAGIAL PETRU PONI.. detalii
REvista de Chimie Revista de Chimie - 70 de ani de aparitie neintrerupta.. detalii
dictionar English-Romanian Dictionary for Mechanical Engineering
(download pdf)
  News, Events
Crossref Member Badge
 DOI  logo
 Gold Open Access | Source=http://www.plos.org/  | Author=art designer at PLoS
Creative Commons License
 Conferences of Contemporary
 Chemistry
 Biblioteca Chimiei
 Materiale Plastice